The genes that code for the human major histocompatibility class I antigens, HLA-A2 and HLA-B7, were introduced into human, monkey, and mouse cell lines by cotransfection with suitable biochemical markers and the fluorescence-activated cell sorter was used to identify and/or select stable cell populations expressing high surface levels of these antigens. Levels of expression obtained were similar to those observed for endogenous HLA antigens on various human cell lines and were 25-80% of those observed on the human Blymphoblastoid cell line JY. Serologically defined HLA-A2 and HLA-B7 polymorphic determinants remained intact on all transfected recipient cells analyzed. Cloned human allospecific cytotoxic T lymphocytes (CTL) specific for HLA-A2 or HLA-B7 were capable of lysing appropriate HLA-transfected human cells with comparable efficiency to JY cell lysis. Two of 10 CTL clones lysed appropriate monkey cell transfectants with :%20% the efficiency of human cell transfectants. No specific lysis of any HLA-transfected mouse cell lines, including a B cell lymphoma, was observed despite comparable levels of surface antigen expression or after induction of higher levels by mouse y-interferon. Furthermore, L cells expressing human 32-microglobulin in addition to HLA-A2 or -B7 were not lysed by these CTL. Thus, an additional species-specific component may be involved in lysis by allogeneic CTL-possibly related to the function(s) of other surface proteins on target cells.
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Human class I antigens, HLA-A, -B, -C, encoded in the major histocompatibility complex (MHC) on chromosome 6, play an important role in self/non-self recognition, serving as restricting elements for cell-mediated lysis by virus-immune cytotoxic T-lymphocytes (CTL) or directly as target antigens for allospecific CTL (reviewed in ref. 1) . As integral membrane glycoproteins, insertion of these highly polymorphic HLA heavy chains (Mr, 44,000) in the membrane is dependent on a noncovalent association with 82-microglobulin (f32m; Mr, 12 ,000) (reviewed in ref. 2) . In somatic cell hybrids, human HLA heavy chains can associate with heterologous 32m for appropriate surface expression (3, 4) .
Multiple genomic sequences that hybridize to class I cDNA probes have been isolated from human, mouse, and porcine gene libraries. Because of the genetic complexity displayed by these multigene families, functional members have been identified using gene-transfer techniques (5-10). The products of mouse H-2 genes introduced into mouse L cells by DNA-mediated gene transfer (DNA-MGT) can be recognized by appropriate monoclonal antibodies (7) (8) (9) and by allospecific or H-2-restricted virus-immune CTL (9, 11, 12) . Although both monomorphic and polymorphic serological determinants of human class I antigens can be detected following DNA-MGT into mouse L cells (5, 6, (13) (14) (15) , recognition by human allospecific CTL or mouse xenogeneic CTL raised against human HLA antigen specificities has not been successful (ref. 14; unpublished results). Recently, however, some xenogeneic CTL clones have been shown to recognize HLA antigens expressed in L cells after DNA-MGT (15) .
To investigate the cellular recognition of HLA antigens in more detail, we have cotransferred human class I genes coding for an A locus and a B locus antigen (HLA-A2 and HLA-B7) with suitable selectable markers into human, monkey, and mouse cell lines. Human allospecific CTL clones recognizing HLA-A2 and HLA-B7 antigens have been established, and they were used to show that human CTL can specifically lyse appropriate HLA-transfected human and monkey but not mouse cells. These results suggest that another species-restricted factor may play a role in the cellular but not serological recognition of human MHC class I proteins.
MATERIALS AND METHODS
Cell Culture. The human osteosarcoma cell line, 143b, and the human rhabdomyosarcoma cell line, RD, obtained from C. Croce (Wistar Institute) and M. Zuniga (California Institute of Technology), respectively, were deficient in thymidine kinase (TK) activity. The African green monkey kidney cell line CV-1, the mouse embryonic liver cell line C127, and the mouse B-lymphoma cell line M12.4.1 were gifts of W. Haseltine (Dana-Farber Cancer Institute), D. DiMaio (Yale University), and L. Glimcher (Harvard Medical School), respectively. Mouse L cells deficient in TK and adenine phosphoribosyltransferase have been described (16) .
Cell lines were maintained in a minimal essential medium (a ME medium; GIBCO) or RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (Microbiological Associates), penicillin (100 units/ml), streptomycin (100 ,ug/ml), and 2 mM glutamine. The RD cell line reverted to a TK+ phenotype at a frequency of 1 x 10-6 and was maintained in a-ME medium containing BrdUrd at 30 ,g/ml.
Effector Cytotoxic T Lymphocytes. Human A2-and B7-specific CTL clones were generated from the peripheral blood lymphocytes (PBL) of a single donor (HLA-A11, Aw32, B27, Bw5l, Cw2; DR7,7). PBL were separated on a Ficoll/Hypaque gradient and stimulated in culture with irradiated JY lymphoblastoid cells (HLA-A2, B7; DR4,6) as described (17) . Each line was stringently subcloned twice by limiting dilution and maintained in complete RPMI medium plus 10% interleukin 2-conditioned supernatants from phyto- and the fluorescence-activated cell sorter was used directly to sort out homogeneous HLA-A2+ or HLA-B7+ subpopulations displaying different levels of expression. HLA-A2-and HLA-B7-expressing cell lines representing the highest levels of surface expression obtained on each recipient line and mock transfectants produced by using only the selectable tk or neo gene are shown in Table 2 . Because the recipient cell lines differ in size, the relative levels of expression of HLA-A2 and HLA-B7 on human, monkey, and mouse transfectants are presented as functions of both total cellular fluorescence and surface antigen density.
Expression levels ranged from 10 to 80% of those found on JY cells. Both the human cell transfectant RDWHS and the mouse cell transfectant C1272B expressed levels of HLA-A2 -25% that of the high-expressing JY cell line (28) but equivalent to that of the endogenous HLA-A2 gene present in the human osteosarcoma line 143b. The HLA-A2' monkey cell line CV1P5 expressed nearly 80% of JY cell total fluorescence but, because of relative cell size differences, the antigen density was only 25% that of JY cells. The mouse L-cell transfectant LTKA2S and the mouse B-cell transfectant MSC expressed 1O0%. As expected, mock transfectants did not express HLA-A2 determinants. Similar results were observed for HLA-B7 transfectants (Table 2, Exp. B).
A panel of HLA-A2-specific mAbs that recognize at least three separate epitopes on the HLA-A2 glycoprotein (29) displayed similar levels of binding to each fILA-A2-transfected cell population (Table 3 ). When any of the different polymorphic mAbs were used, the comparative levels of expression among cell lines remained relatively constant. A small increase in MA2.1 antibody binding was reproducibly observed on the monkey and mouse cell transfectants but not on the human cell lines assayed. The significance of these small differences is not clear, but they may indicate minor conformational alterations or processing differences of the HLA-A2 glycoprotein in the different cell backgrounds.
Similar results were observed with a panel of HLA-B7-reactive mAbs (Table 4 ). mAbs BB7.1, MB40.2, MB40.3, and ME1 bound to all human, monkey, and mouse cell transfectants and displayed similar relative levels of expression among the transfectants. Thus, comparative quantitative binding of the HLA-A2-and HLA-B7-specific mAbs that recognize different epitopes on the appropriate molecules established that these proteins are expressed in association with either human, monkey, or mouse f32m, without significant conformational alteration of these epitopes. "Cr-labeled target cells (1 x 103) were incubated at various E:T ratios with the indicated CTL effector cells in 96-well round-bottomed microtiter plates at 37°C for 4 hr. Supernatants were harvested after centrifugation and % specific "Cr release was calculated as 100 x ("Cr released by immune lymphocytes -spontaneous "'Cr release)/(maximal "'Cr released with Triton X-100 -spontaneous "'Cr release). Spontaneous release was <20% of maximal release
and SD values among triplicate samples were <5%. *None, mock-infected cells.
al HLA-A2-specific CTL clones (CTL-A2.2-A2.5) demonstrated a similar ability to lyse HLA-A2-transfected human RD cells. However, these clones were unable to lyse HLA-A2-expressing monkey cells. Thus, isolated HLA-A2-and -B7-specific CTL exhibit at least two patterns of reactivityrecognition of both human and monkey transfectants and recognition of human transfectants only. Because the level of expression of HLA-A2 on L-cell transfectants was only 10% of that on JY cells, mouse yinterferon (y-IFN) was used to induce higher levels of expression (30) . Even after an 8-to 10-fold induction of HLA expression by mouse y-IFN, no lysis by human allospecific CTL was seen (Table 6 ). Furthermore, the mouse B lyrnphoma M12.4. 1, transfected with HLA-A2 or HLA-B7 genes and expressing moderately high levels of these surface proteins, was not lysed specifically by human CTL clones (Table 7) .
To address whether this lack of killing may be due to conformational changes of the HLA-A2 or HLA-B7 heavy chains due to association with mouse /32m, the HLA-A2 gene was introduced into L cells already expressing high levels of human 82m (31) . Surface levels of expression of HLA were typically higher on these transfected cells than on L-cell transfectants (both by mass population or clonal analysis). No lysis of these transfectants expressing good levels of HLA-A2 and human f32m by CTL clone CTL-A2.2 was observed (Table 8) . Because recent experiments suggest that HLA-bound surface 32m in L cells may exchange to various degrees with bovine 832m in culture medium (32) , these transfectants were also grown in human serum. Again, no lysis by CTL clones was observed. Thus, the absence of killing is not explained solely by association of HLA heavy chains with mouse or bovine f32m.
DISCUSSION
Most, if not all, monomorphic and polymorphic serological determinants of human class I antigens remain intact after transfection of their genes into mouse L cells by DNA-MGT (refs. 5, 6, 13-15, and data presented here). However, the same mouse L cells expressing transfected HLA antigens serve as poor targets for human allospecific CTL (14) . Here, we report that human allospecific CTL can recognize and lyse human and monkey, but not mouse, cells transfected with HLA class I genes. Furthermore, the lack of CTL lysis of mouse cells expressing HLA antigens is not limited to mouse L cells, because neither mouse B-cell nor mouse Lcell transfectants could be lysed. Therefore, a more general species-related phenomenon may be involved.
One possible explanation for the lack of killing of mouse transfectants is the low level of HLA antigen expression seen on most L-cell transfectants. These cells expressed only 10-30% of JY cell levels, which may not be sufficient Proc. NatL Acad Sd USA 81 (1984) Proc. NatL Acad Sci USA 81 (1984) 7553
for successful CTL-mediated lysis. However, human cell transfectants expressing similarly low levels have been specifically lysed, albeit at a lower efficiency (e.g., 143b7E). Furthermore, CTL did not lyse the mouse C127 transfectants even though their levels of HLA expression were identical to those of human RD transfectants. Finally, even after an 8-to 10-fold induction of HLA expression by mouse yinterferon, no lysis by human allospecific CTL was observed. Thus, although surface expression levels or antigen density may affect the overall efficiency of lysis of human cell transfectants, it does not explain the total absence of lysis observed on mouse cell transfectants. Furthermore, interferon treatment does not induce the expression of other factors that may be necessary to mediate this lysis. Lack of lysis of mouse cell transfectants by human allospecific CTL could be due to conformational changes of heavy chain determinants as a result of association with mouse, rather than human, 82m. These conformational changes may affect CTL-defined HLA-A2 and -B7 antigenic determinants to a greater degree than serologically defined determinants. However, association with mouse A32m is not likely to explain the species-restricted recognition described here, as transfected mouse L cells expressing both human A32m (31) and HLA-A2 or HLA-B7 were not lysed by our human allospecific CTL. Such experiments are complicated by the observation that surface f32m bound to HLA or H-2 may exchange to various degrees with bovine A32m in culture medium (32) . However, even after growth of our mouse cell transfectants in human serum, lysis did not occur. Similar results have been obtained by others (33) . Furthermore, in murine systems where 2m exchange is also possible, no effects were observed on the successful lysis of these H-2-transfected mouse L cells by murine CTL (9, 11, 12) .
Alternative explanations for why human allospecific CTL recognize human cells and not mouse cells expressing transfected HLA antigens seem more likely. For example, (0) although gross structural alterations have not been seen (14) , slight differences in processing of the human class I molecule in mouse and human cells (e.g., glycosylation) may occur that mask or alter CTL antigenic determinants; (ii) since antigen-specific CTL mediated killing is a multistep process involving antigen recognition and adhesion, delivery of the lethal hit, and target cell lysis (34) , these human CTL clones may recognize appropriate transfected mouse cell targets but not effectively transmit a lytic signal; (iii) other species-specific cell interaction molecules, such as LFA-1, -2, -3 (35) or their ligands, that would increase the ability of the T cell to bind its target may be required; and (iv) the possibility that allospecific CTL may in fact recognize self-HLA plus X, where X may be structurally different on mouse and human cells. It is of interest that some mouse xenogeneic CTL clones have been shown to recognize HLA antigens expressed on mouse L cells after DNA-MGT (15) . Whether these clones are of high affinity, bypassing the need of other cell surface molecules, or are less dependent on slight conformational or processing changes is unclear. Regardless of which explanation provides the key to lysis of HLA-transfected mouse cells, the successful recognition of human cell transfectants described here provides a model system to study further the cellular recognition of human MHC class I molecules through molecular alteration of the transfected gene.
